# Genvax Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genvax-technologies

- Industry: Biotechnology
- Headquarters: Ames, US
- Website: www.genvax.com/
- Total disclosed funding: $13M
- Latest round: Seed (Feb 3, 2025)
- Investors on record: 7

## About

Founded in 2021 and based in Iowa, US, Genvax Technologies, Inc. operates as a biotechnology company that enagges in the development of vaccines for animal disease prevention and treatment. In February 2025, Genvax Technologies, Inc. raised seed funding led by investor United Animal Health, Inc. along with other investors, Johnsonville Ventures and Iowa Corn Opportunities. The firm as of February 2025, is led by its co-founders, Joel Harris (CEO) and Hank Harris.

Genvax Technologies specializes in the development of mRNA and nanoparticle vaccines aimed at the prevention and treatment of animal diseases. Their core product offerings focus on enhancing vaccine efficacy through precise gene integration, which is essential for addressing specific health challenges in livestock. By leveraging advanced biotechnology, Genvax seeks to improve animal health outcomes, thereby benefiting farmers and the agricultural industry as a whole. The company primarily serves livestock producers and veterinarians in the United States and select international markets, focusing on regions with significant livestock populations. These vaccines are designed to ensure the health and productivity of animals, addressing critical end use cases such as disease prevention in cattle, poultry, and swine.

Genvax Technologies operates on a B2B model, engaging directly with livestock producers and veterinary clinics to supply its vaccine products. The company’s revenue structure includes sales of individual vaccine doses or bulk supply agreements tailored to the needs of agricultural clients.

The company plans to utilize the February 2025 funding to advance USDA approval of its vaccines for animal disease outbreaks. The company is also focused on designing and launching new vaccine products targeting specific diseases in livestock, with plans to expand its reach into new markets, particularly regions with high livestock concentrations, by mid-2025.

## Funding rounds

- Seed, Feb 3, 2025 — Next Level Ventures, Iowa Corn Opportunities, Iowa Farm Bureau Federation, Johnsonville Ventures, United Animal Health, Inc.
- Seed, Aug 10, 2022, $6.5M — Summit Ag Investors, Iowa Corn Opportunities, Ag Startup Engine, Johnsonville Ventures, United Animal Health, Inc.
- Seed, Jun 2, 2022, $6.4M — Summit Ag Investors, Iowa Corn Opportunities, Ag Startup Engine, Johnsonville Ventures, United Animal Health, Inc.

## Investors

- Summit Ag Investors (https://capitalatlas.ai/funds/summit-ag-investors) — Seed
- Iowa Corn Opportunities (https://capitalatlas.ai/funds/iowa-corn-opportunities) — Seed
- Ag Startup Engine (https://capitalatlas.ai/funds/ag-startup-engine) — Seed
- Johnsonville Ventures (https://capitalatlas.ai/funds/johnsonville-ventures) — Seed
- United Animal Health, Inc. — Seed
- Next Level Ventures (https://capitalatlas.ai/funds/next-level-ventures) — Seed
- Iowa Farm Bureau Federation — Seed